In AML cell lines, low concentrations of AICAr and brequinar were shown to exert synergistic effects on both cell cycle arrest in S-phase and cellular differentiation, and the effects of both agents depended on the activation of DNA damage ATR/Chk1 signaling pathway [13]. This evidence concerns the gene CHEK1 and acute myeloid leukemia.